ČEŠKOVÁ, Eva, Tomáš KAŠPÁREK, Ivana PALČÍKOVÁ, Jan DUFEK, Darja VALENTOVÁ and Růžena DOČKALOVÁ. The effect of treatment on BMI, attitudes and psychopathology in eating disorders. European Neuropsychopharmacology ON LINE. Amsterdam (The Netherlands): Elsevier, 2008, vol. 18, suppl. 4, p. 330-330. ISSN 0924-977X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The effect of treatment on BMI, attitudes and psychopathology in eating disorders
Name in Czech Efekt při léčbě BMI, přístupy a psychopatologie při poruchách příjmu potravy
Name (in English) The effect of treatment on BMI, attitudes and psychopathology in eating disorders
Authors ČEŠKOVÁ, Eva, Tomáš KAŠPÁREK, Ivana PALČÍKOVÁ, Jan DUFEK, Darja VALENTOVÁ and Růžena DOČKALOVÁ.
Edition European Neuropsychopharmacology ON LINE, Amsterdam (The Netherlands), Elsevier, 2008, 0924-977X.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.661
Organization unit Faculty of Medicine
UT WoS 000259593801014
Keywords in English BMI; SSRI; psychopathology; eating disorders
Tags bmi, eating disorders, psychopathology, SSRI
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Eva Češková, CSc., učo 726. Changed: 17/6/2009 10:32.
Abstract
Taken together, the observed differences in the mirtazapine and SSRIs effect on the psychopathology reflect the preferential use of these two groups of antidepressants in bulimia and anorexia nervosa respectively. Clinicians apparently try to target the core clinical features of the eating disorders: SSRIs were given to bulimia patients with high scores of impulsivity, of mirtazapine in the anorexia nervosa patients might reflect the clinical utilization of its adverse effect on weight.
Abstract (in English)
Taken together, the observed differences in the mirtazapine and SSRIs effect on the psychopathology reflect the preferential use of these two groups of antidepressants in bulimia and anorexia nervosa respectively. Clinicians apparently try to target the core clinical features of the eating disorders: SSRIs were given to bulimia patients with high scores of impulsivity, of mirtazapine in the anorexia nervosa patients might reflect the clinical utilization of its adverse effect on weight.
Links
MSM0021622404, plan (intention)Name: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS
Investor: Ministry of Education, Youth and Sports of the CR, The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.
PrintDisplayed: 19/7/2024 10:11